(Q35234799)

7 August 2017

title

Matrix metalloproteinase-9 in an exploratory trial of intravenous minocycline for acute ischemic stroke (English)

1 reference

7 August 2017

1 reference

Jeffrey A Switzer

1

1 reference

7 August 2017

David C Hess

2

1 reference

7 August 2017

Adviye Ergul

3

1 reference

7 August 2017

Jennifer L Waller

4

1 reference

7 August 2017

Livia S Machado

5

1 reference

7 August 2017

Vera Portik-Dobos

6

1 reference

7 August 2017

L Creed Pettigrew

7

1 reference

7 August 2017

Wayne M Clark

8

1 reference

7 August 2017

Susan C Fagan

9

1 reference

7 August 2017

language of work or name

English

0 references

publication date

7 July 2011

1 reference

7 August 2017

1 reference

7 August 2017

volume

42

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

2633-2635

1 reference

Minocycline to improve neurologic outcome in stroke (MINOS): a dose-finding study

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3181080

Extension of the thrombolytic time window with minocycline in experimental stroke.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3181080

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3181080

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3181080

Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3181080

Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3181080

Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3181080

Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3181080

Matrix Metalloproteinase Expression After Human Cardioembolic Stroke

26 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21737808

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1161/STROKEAHA.111.618215

1 reference

7 August 2017

1 reference

7 August 2017

1 reference